Broncomar
NDC Package 70242-101-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Broncomar is other Information:Each 5 mls contains: sodium 8 mgStore between 15 - 30 degrees Celsius (59 - 86 Fahrenheit). Marketed by Dannso Corp./d.b.a. Essential Products, this product is identified by NDC 70242-101 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
70242-101-06
Package Description
1 BOTTLE in 1 CARTON / 177 mL in 1 BOTTLE
Product Code
70242-101
11-Digit Billing Format
70242010106
RxNorm Crosswalk
  • RxCUI: 996520 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution
  • RxCUI: 996520 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Broncomar DM
Dosage Form
-
Usage Information
Other Information:Each 5 mls contains: sodium 8 mgStore between 15 - 30 degrees Celsius (59 - 86 Fahrenheit). Tamper Evident Feature:Do not use if seal under cap is torn, broken or missing.

Regulatory & Marketing

Labeler Name
Dannso Corp./d.b.a. Essential Products
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-01-2001
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70242-101-06 identifies a specific commercial package of 1 bottle in 1 carton / 177 ml in 1 bottle of Broncomar DM, labeled by Dannso Corp./d.b.a. Essential Products. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dannso Corp./d.b.a. Essential Products on October 01, 2001. The current certification is valid through December 31, 2021.

How is this Dannso Corp./d.b.a. Essential Products product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70242010106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70242-101-06
11-Digit CMS (5-4-2)
70242-0101-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.